Investment focus and strategy

The investment focus of CapMan Life Science is on medical technology and healthcare services.

Where do we invest?

• primarily Nordic companies and selectively the rest of Europe
• the products or services of our portfolio companies satisfy direct and long-term customer demands, and typically enable better treatment outcome at a lower cost. 
• net sales between €2–20 million
• investment size typically €2–7 million equity (Life Science funds)

What do we look for?

• a proven business model and approved products/services
• significant domestic or international growth potential, organically or via add-on acquisitions
• –an experienced, entrepreneurial executive team